Metabolic syndrome increases mortality risk in women with high-risk HPV

Using large-scale U.S. data following patients for more than a decade, York University Faculty of Health researchers found that women with both metabolic syndrome and high-risk strains of human papillomavirus (HPV) are at a 2.6 times higher risk for mortality than women without either condition, suggesting a need to look at chronic disease comorbidity when it comes to HPV-related cancers.

Related Keywords

Canada ,Sunnybrook ,Alberta ,United States ,Canadian ,Parmis Mirzadeh ,Buick ,Sunnybrook Health Sciences Centre ,School Of Kinesiology ,Nutrition Examination ,United States National Health ,Health Science Ph ,School Of Nursing Assistant Professor Catriona Buick ,York University ,York University Faculty Of Health ,York University Faculty ,Nursing Assistant Professor Catriona Buick ,Oncology Nurse Clinician Scientist ,Sunnybrook Health Sciences ,Health Science Phd ,Nutrition Examination Survey ,Assistant Professor ,